Arrivent Biopharma, Inc. · NASDAQ:AVBP
BlackRock, Inc. reported a 6.80% stake in Arrivent Biopharma, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 27, 2026
BlackRock, Inc. reported a 6.80% stake in Arrivent Biopharma, Inc., 3,182,080 shares, as a passive investor on Jun 30, 2026. Filed Jul 27, 2026 (Schedule 13G/A).
- Stake
- 6.80%
- Shares
- 3,182,080
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 6.80% | 3,182,080 |
Source
Related
- Arrivent Biopharma, Inc.
- BlackRock, Inc.
- Arrivent Biopharma, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Jan 21, 2026
- Schedule 13G/A · BlackRock, Inc. · Oct 17, 2025
- Schedule 13G · Vivo Opportunity, LLC · Oct 13, 2026
- Schedule 13D/A · Orbimed Advisors LLC · Oct 8, 2026
- Schedule 13G/A · FMR LLC · May 6, 2026
- Schedule 13G/A · Sofinnova Venture Partners IX, L.P. ("SVP IX") · Mar 5, 2026
- Schedule 13G/A · Hillhouse Investment Management, Ltd. · Feb 17, 2026